Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Bateman

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
The European Respiratory Journal|August 26, 2017
Fevipiprant, an oral prostaglandin DP<sub>2</sub> receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroidsEric D Bateman, Alfredo G Guerreros, Florian Brockhaus, et al.
BMC Public Health|October 9, 2021
Correction to: Global asthma prevalence in adults: findings from the cross-sectional world health surveyTeresa To, Sanja Stanojevic, Ginette Moores, et al.
BMC Public Health|March 21, 2012
Global asthma prevalence in adults: findings from the cross-sectional world health surveyTeresa To, Sanja Stanojevic, Ginette Moores, et al.
Respiratory Research|August 3, 2015
Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Eric D Bateman, Kenneth R Chapman, Dave Singh, et al.
The European Respiratory Journal|January 28, 2012
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved careLouis-Philippe Boulet, J Mark FitzGerald, Mark L Levy, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthmaEric D Bateman, Theo A Bantje, Maria João Gomes, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Efficacy and safety of roflumilast in the treatment of asthmaEric D Bateman, Jose Luis Izquierdo, Ulf Harnest, et al.
Thorax|May 1, 2012
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonDonald A Mahler, Anthony D'Urzo, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaPaul M O'Byrne, Hans Bisgaard, Philippe P Godard, et al.
BMC Pulmonary Medicine|April 22, 2017
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatmentChristine R Jenkins, Göran Eriksson, Eric D Bateman, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
The European Respiratory Journal|August 26, 2017
Fevipiprant, an oral prostaglandin DP<sub>2</sub> receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroidsEric D Bateman, Alfredo G Guerreros, Florian Brockhaus, et al.
BMC Public Health|October 9, 2021
Correction to: Global asthma prevalence in adults: findings from the cross-sectional world health surveyTeresa To, Sanja Stanojevic, Ginette Moores, et al.
BMC Public Health|March 21, 2012
Global asthma prevalence in adults: findings from the cross-sectional world health surveyTeresa To, Sanja Stanojevic, Ginette Moores, et al.
Respiratory Research|August 3, 2015
Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Eric D Bateman, Kenneth R Chapman, Dave Singh, et al.
The European Respiratory Journal|January 28, 2012
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved careLouis-Philippe Boulet, J Mark FitzGerald, Mark L Levy, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthmaEric D Bateman, Theo A Bantje, Maria João Gomes, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Efficacy and safety of roflumilast in the treatment of asthmaEric D Bateman, Jose Luis Izquierdo, Ulf Harnest, et al.
Thorax|May 1, 2012
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonDonald A Mahler, Anthony D'Urzo, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaPaul M O'Byrne, Hans Bisgaard, Philippe P Godard, et al.
BMC Pulmonary Medicine|April 22, 2017
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatmentChristine R Jenkins, Göran Eriksson, Eric D Bateman, et al.
Pageof 17